TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced operating and financial results for the fourth quarter and year ended December 31, 2008. EpiCept’s net loss for the fourth quarter was $5.4 million, or $0.07 per share, and for the year was $25.4 million, or $0.41 per share. As of December 31, 2008, EpiCept had cash and cash equivalents of $0.8 million, and approximately 82.5 million shares outstanding. In February 2009 the Company raised $15.6 million, before payment of fees and expenses, through the issuance of convertible subordinated notes.
